{"title":"Characterization and Application of a Thermostable HAD Phosphatase From Thermophilibacter mediterraneus for Glucosamine Production","authors":"Yanmei Qin, Nan Geng, Chun You","doi":"10.1002/biot.70083","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Glucosamine (GlcN), a high-value nutraceutical, is currently produced via environmentally detrimental chitin hydrolysis or inefficient microbial fermentation. While acidic hydrolysis of crustacean chitin raises environmental and allergen concerns, microbial fermentation faces challenges in strain engineering and byproduct formation. One-pot production of GlcN from maltodextrin by an in vitro synthetic enzymatic biosystem (ivSEB) containing glucosamine 6-phosphate phosphatase, which dephosphorylates glucosamine 6-phosphate (GlcN6P) to GlcN, was developed recently. In this study, we identified a thermostable haloacid dehalogenase (HAD) phosphatase, TmHAD, from <i>Thermophilibacter mediterraneus</i> through database mining. Biochemical characterization revealed its remarkable dephosphorylation specificity for GlcN6P, exhibiting 27.6- and 138.0-fold higher activity toward GlcN6P compared to glucose 6-phosphate (G6P) and fructose 6-phosphate (F6P), respectively. The enzyme demonstrated Mg<sup>2+</sup>-dependent activity and moderate thermal stability with a half-life of 6.6 h at 45°C. When incorporated into an ivSEB (phosphorylation, isomerization, amination, and dephosphorylation), TmHAD enabled GlcN production from maltodextrin with a molar yield of 44.5%. This biosystem represented an effective complement to current GlcN production methods, with the exceptional substrate specificity and thermal stability of TmHAD making it particularly promising for industrial-scale GlcN manufacturing in vitro.</p>\n </div>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"20 7","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/biot.70083","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Glucosamine (GlcN), a high-value nutraceutical, is currently produced via environmentally detrimental chitin hydrolysis or inefficient microbial fermentation. While acidic hydrolysis of crustacean chitin raises environmental and allergen concerns, microbial fermentation faces challenges in strain engineering and byproduct formation. One-pot production of GlcN from maltodextrin by an in vitro synthetic enzymatic biosystem (ivSEB) containing glucosamine 6-phosphate phosphatase, which dephosphorylates glucosamine 6-phosphate (GlcN6P) to GlcN, was developed recently. In this study, we identified a thermostable haloacid dehalogenase (HAD) phosphatase, TmHAD, from Thermophilibacter mediterraneus through database mining. Biochemical characterization revealed its remarkable dephosphorylation specificity for GlcN6P, exhibiting 27.6- and 138.0-fold higher activity toward GlcN6P compared to glucose 6-phosphate (G6P) and fructose 6-phosphate (F6P), respectively. The enzyme demonstrated Mg2+-dependent activity and moderate thermal stability with a half-life of 6.6 h at 45°C. When incorporated into an ivSEB (phosphorylation, isomerization, amination, and dephosphorylation), TmHAD enabled GlcN production from maltodextrin with a molar yield of 44.5%. This biosystem represented an effective complement to current GlcN production methods, with the exceptional substrate specificity and thermal stability of TmHAD making it particularly promising for industrial-scale GlcN manufacturing in vitro.
Biotechnology JournalBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍:
Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances.
In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office.
BTJ promotes a special emphasis on:
Systems Biotechnology
Synthetic Biology and Metabolic Engineering
Nanobiotechnology and Biomaterials
Tissue engineering, Regenerative Medicine and Stem cells
Gene Editing, Gene therapy and Immunotherapy
Omics technologies
Industrial Biotechnology, Biopharmaceuticals and Biocatalysis
Bioprocess engineering and Downstream processing
Plant Biotechnology
Biosafety, Biotech Ethics, Science Communication
Methods and Advances.